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Morphogens act in developing tissues to control the spatial arrangement of cellular differentiation 1, 2 . The activity of a morphogen has generally been viewed as a concentration-dependent response to a diffusible signal, but the duration of morphogen signalling can also affect cellular responses 3 . One such example is the morphogen sonic hedgehog (SHH). In the vertebrate central nervous system and limbs, the pattern of cellular differentiation is controlled by both the amount and the time of SHH exposure [4] [5] [6] [7] . How these two parameters are interpreted at a cellular level has been unclear. Here we provide evidence that changing the concentration or duration of SHH has an equivalent effect on intracellular signalling. Chick neural cells convert different concentrations of SHH into time-limited periods of signal transduction, such that signal duration is proportional to SHH concentration. This depends on the gradual desensitization of cells to ongoing SHH exposure, mediated by the SHH-dependent upregulation of patched 1 (PTC1), a ligand-binding inhibitor of SHH signalling 8 . Thus, in addition to its role in shaping the SHH gradient [8] [9] [10] , PTC1 participates cell autonomously in gradient sensing. Together, the data reveal a novel strategy for morphogen interpretation, in which the temporal adaptation of cells to a morphogen integrates the concentration and duration of a signal to control differential gene expression.
How both concentration and duration of morphogen signalling determine cell pattern is poorly understood 1 (see Supplementary Fig.  1a ). We focused on three transcription factors that respond to differential SHH signalling in progenitors of the neural tube. OLIG2 and NKX2.2, expressed in the ventral neural tube of chick (Fig. 1a) , depend on SHH signalling for their expression 4, 11, 12 . In contrast, PAX7 expression is repressed by SHH signalling 13 and is restricted to dorsal neural tube progenitors (Fig. 1a) . We confirmed that these proteins respond to different levels of SHH signalling using an ex vivo assay of intermediate region naive neural plate explants 14 ( Fig. 1b-d ). In agreement with previous studies 13, 15 , changes in SHH concentration controlled the expression of these genes in a manner corresponding to their in vivo expression patterns (Fig. 1e) . Similar gene expression responses were obtained by generating, in vivo, a gradient of GLI transcriptional activity 16, 17 , the transcriptional effectors of SHH signalling. Furthermore, manipulation of the activity of the transmembrane protein smoothened (SMO), which transduces SHH signalling intracellularly 18 , was also sufficient to confer graded responses to neural cells ( Supplementary Fig. 2 ).
We asked how the response of cells to SHH develops over time. We assayed intermediate region neural plate explants exposed to SHH for 6 h to 24 h (Fig. 1f, g (Fig. 1f, g ). Thus, during the first 12 h, $1 nM SHH generated similar amounts of OLIG2 induction (Supplementary Table 1 ). Only after 12 h were distinct responses apparent. By 18 h, OLIG2 and NKX2.2 co-expression was evident in some progenitors treated with $2 nM SHH (Fig. 1f) . These results are consistent with the sequential onset of OLIG2 and NKX2.2 expression in vivo 10, 17 . Furthermore, the explant data predict that, in vivo, NKX2.2 should be induced in cells that previously expressed OLIG2. Genetic lineage tracing in mice harbouring an Olig2 allele engineered to encode Cre recombinase confirmed this (Fig. 1h) . Thus, compared to OLIG2, induction of NKX2.2 requires a higher concentration and longer duration of SHH exposure.
To investigate the reason for the temporal and concentration dependence of the response, we analysed the output of the SHH signal transduction pathway. We assayed GLI activity using a reporter plasmid 19 (GBS-Luc; see Fig. 2a and Methods). Taking advantage of the short half-life of luciferase 20 (,3 h), we measured GBS-Luc activity every 6 h. For concentrations of SHH $1 nM, GLI activity was similar during the first 12 h (Fig. 2a) , the period when these concentrations induce OLIG2. Then, with the exception of the highest SHH concentration, GLI activity decreased over time, with a rate inversely proportional to SHH concentration (Fig. 2a) . Notably, the time at which 1 nM and 4 nM SHH produced differences in the level of GLI activity corresponded to the detection of differences in gene expression (Fig. 1f , g and Supplementary Table 1 ). The data indicate, therefore, that cells become progressively desensitized to ongoing SHH signalling ( Supplementary Fig. 1 ). Initially 1 nM and 4 nM SHH produce similar levels of GLI activity, then the level of GLI activity begins to fall, with a higher rate of decrease in cells exposed to lower concentrations. This suggests a mechanism for gradient sensing in which 'temporal adaptation' to the ligand transforms the extracellular concentration of morphogen into a time-limited period of signal transduction, such that the duration of signalling is proportional to ligand concentration.
This model predicts that the response of cells relies not only on the level but also on the duration of intracellular signal transduction. To test this, we compared GLI activity and gene expression in neural cells containing an endogenous source of SHH. In explants consisting of SHH-producing notochord and floor plate together with ventral regions of the neural tube (hereafter called NVF explants), the expression of OLIG2 and NKX2.2 was induced sequentially, 12 h and 18 h after the start of culture, respectively ( Fig. 2f-h ). During this period the level of GLI activity remained approximately constant, confirming that the switch to NKX2.2 expression was not associated with an increase in GLI activity (Fig. 2b , f-h). To examine whether the maintenance of an OLIG2-expressing state depends on the downregulation of GLI activity, NVF explants were cultured for 12 h and then transferred to media containing cyclopamine, a small-molecule antagonist of SHH signalling ( Supplementary Fig. 2 ). GLI activity and gene expression were monitored at 18 h (Fig. 2c-e, i) . Addition of 200 nM cyclopamine at 12 h resulted in a twofold decrease in GLI activity and a failure to induce NKX2.2 expression (Fig. 2c , e, i) without inhibiting OLIG2 expression. Furthermore, addition of 400 nM cyclopamine inhibited GLI activity to background levels, leading to a complete loss of NKX2.2 expression and a decrease in the number of OLIG2-expressing cells (Fig. 2c , e, and data not shown). These data indicate that the duration of GLI activity is crucial for determining the cellular response to SHH. To test the converse prediction of the model, we assayed the effect of extending the period of SHH signalling (Fig. 2j) . Consistent with the model, prolonging SHH signalling resulted in peak OLIG2 and NKX2.2 induction at lower SHH concentrations after 48 h of exposure compared to 24 h and 36 h (Fig. 2j) .
Two mechanisms that could account for the adaptation of cells to SHH signalling are the loss of a factor necessary for signal transduction or the induction of inhibitors of signal transduction, such as the SHH-binding protein PTC1 (refs 21-23) . We assessed GLI activity in a time series of intermediate region neural plate explants in which SHH signalling was induced using purmorphamine, a small-molecule agonist of SMO 24 ( Fig. 3a and Supplementary Fig. 2 ). In contrast to the response of neural cells to SHH (Fig. 2a) , even though a diminution in GLI activity was observed in treated cells, there was no correlation between the rate of decrease and the concentration of purmorphamine (Fig. 3a) . This suggests that the profile of GLI activity evoked by SHH is shaped mainly by an adaptation mechanism acting upstream of SMO.
As PTC1 is a well-established inhibitor of SHH signalling 8 , we tested whether it is required cell autonomously for the temporal adaptation of cells to SHH. Small interfering RNAs (siRNAs) were used to block chick PTC1 (cPTC1) induction (Fig. 3b and Supplementary Figs  3-6) . In ovo transfection of cPTC1 siRNAs inhibited the upregulation of cPTC1 but did not completely abolish its expression ( Supplementary  Fig. 4 , and data not shown). As a result, and consistent with observations in mouse embryos containing an un-inducible allele of Ptc1 10 , ventralization of the neural tube, but no ligand-independent SHH signalling, was observed in siRNA-transfected embryos or in intermediate region neural plate explants (Supplementary Figs 3 and 5) . We therefore assayed whether blocking cPTC1 upregulation altered ;ROSA26-flox-STOP-floxlacZ E10.5 mouse embryos. the response of cells to SHH exposure. Explants were transfected with control or cPTC1 siRNAs and exposed to 0.25-1 nM SHH. Transfection of control siRNAs did not change the gene expression profile induced by SHH (Fig. 3b) . However, in contrast to control explants exposed to 1 nM SHH that predominately expressed OLIG2, increased numbers of NKX2.2-expressing cells were observed in 1 nM SHHtreated intermediate region neural plate explants transfected with cPTC1 siRNAs. A similar result was obtained when siRNAs were transfected individually (Supplementary Fig. 6 ). The siRNA effect was dependent on SHH concentration: cPTC1 siRNAs did not alter the response of intermediate region neural plate explants exposed to ,0.5 nM SHH, indicating that the blockade of cPTC1 upregulation does not result in NKX2.2 induction in response to all concentrations of SHH. These data indicate that gradient sensing requires upregulation of PTC1. This complements the previously identified ability of PTC1 to influence the spread of ligand by sequestering SHH protein [8] [9] [10] . Thus, upregulation of PTC1 by SHH has both cell autonomous and nonautonomous functions in morphogen interpretation.
Adaptation to extracellular signals has previously been proposed to permit the sensing and transduction of a signal over large concentration ranges 25, 26 . This study indicates that the same strategy is used to measure the concentration of a ligand during developmental patterning. The progressive adaptation of cells to SHH transforms ligand exposure into periods of increased GLI activity, the duration of which is proportional to SHH concentration (Fig. 3c) . This allows cells to integrate both the concentration and duration of a graded morphogen ( Supplementary Fig. 1 ). The transduction of a morphogen concentration into a duration of transcriptional activity offers an alternative to the established mechanisms of graded signalling 27, 28 , which explains how the amount and duration of SHH exposure determine similar cellular responses 3, 6, 7 .
METHODS SUMMARY
Neural plate explants, immunohistochemistry and in situ hybridization. Explants isolated from Hamburger and Hamilton (HH) stage 10 chick embryos were cultured as described 13, 14 . Cyclopamine (Toronto Research Chemicals) and purmorphamine (Calbiochem) were dissolved in 100% ethanol and DMSO, respectively. Reagents and protocols for immunohistochemistry and in situ hybridization have been described [12] [13] [14] 29 . Chick in ovo electroporation, luciferase assays and siRNAs. HH stage 10 embryos were electroporated in ovo and incubated for 2 h before dissecting explants. Luciferase assays with GBS-Luc 19 were carried out as previously described 17 . RNA duplexes targeting chick PTC1 and, as a control, human lamin were from Dharmacon. These were co-electroporated in ovo with a plasmid expressing green fluorescent protein.
Olig2-Cre lineage tracing. Olig2-Cre mice were generated in the Jessell laboratory, Columbia University. Standard homologous recombination procedures were used to replace exon 2 of the Olig2 locus with Cre recombinase. Olig2-Cre/ 1 mice were mated with ROSA26 reporter mice 30 , and embryos analysed at E10.5.
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature. 
